Latest Articles
Heart disease to impact one in three young women by 2050 - Women's Agenda
Heart disease to impact one in three young women by 2050 Women's Agenda
Published: Feb. 25, 2026, 11:58 p.m.
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 - The Manila Times
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026 The Manila Times
Published: Feb. 24, 2026, 1:17 p.m.
PCOS Long-Term Health Risks: From Infertility And Type 2 Diabetes To Heart Disease And Endometrial Cancer - TheHealthSite
PCOS Long-Term Health Risks: From Infertility And Type 2 Diabetes To Heart Disease And Endometrial Cancer TheHealthSite
Published: Feb. 23, 2026, 1:56 p.m.
Walmart Black Friday Deals event: Get a Dyson V12 for under $400 - Mashable
Walmart Black Friday Deals event: Get a Dyson V12 for under $400 Mashable
Published: Feb. 22, 2026, 10 a.m.
Valentine's Day gift idea: Get a free Heart Cocotte at Le Creuset with purchase - Mashable
Valentine's Day gift idea: Get a free Heart Cocotte at Le Creuset with purchase Mashable
Published: Feb. 21, 2026, 10 a.m.
'This warms my heart', say fans as RTE First Dates stars reveal they're expecting baby 3 months after filming show - The Irish Sun
'This warms my heart', say fans as RTE First Dates stars reveal they're expecting baby 3 months after filming show The Irish Sun
Published: Feb. 20, 2026, 7:06 p.m.
Femtech FimmCyte closes wide-ranging agreement with Richter - Startupticker.ch
Femtech FimmCyte closes wide-ranging agreement with Richter Startupticker.ch
Published: Feb. 19, 2026, 5:01 p.m.
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa
Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa
Published: Feb. 19, 2026, 12:54 a.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria
Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria
Published: Feb. 18, 2026, 11:46 p.m.
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment - Femtech Insider
FimmCyte Partners with Gedeon Richter to Advance Non-Hormonal Endometriosis Treatment Femtech Insider
Published: Feb. 18, 2026, 3:18 p.m.
Link copied to clipboard!